Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Neal

Showing results (271-280 of 484) with videos related to

Pageof 49
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 20, 2003
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibitionStephen B Harrap, Christophe Tzourio, François Cambien, et al.
Clinical Trials (London, England)|February 20, 2008
Do we need to adjudicate major clinical events?Christopher B Granger, Victor Vogel, Steve R Cummings, et al.
Food Research International (Ottawa, Ont.)|May 31, 2021
The adaptation, validation, and application of a methodology for estimating the added sugar content of packaged food products when total and added sugar labels are not mandatoryTailane Scapin, Jimmy Chun Yu Louie, Simone Pettigrew, et al.
BMC Public Health|May 13, 2016
Effects of a community-based salt reduction program in a regional Australian populationMary-Anne Land, Jason H Y Wu, Adriana Selwyn, et al.
JAMA Cardiology|February 5, 2025
Salt Substitution and Recurrent Stroke and Death: A Randomized Clinical TrialXiong Ding, Xinyi Zhang, Liping Huang, et al.
Diabetes Care|June 20, 2022
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)Ele Ferrannini, Simona Baldi, Tiziana Scozzaro, et al.
Circulation|November 15, 2017
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Kenneth W Mahaffey, Bruce Neal, Vlado Perkovic, et al.
The International Journal of Behavioral Nutrition and Physical Activity|December 12, 2022
Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panelDaisy H Coyle, Liping Huang, Maria Shahid, et al.
The Lancet. Planetary Health|December 14, 2024
The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trialBenjamin Talbot, Robert A Fletcher, Bruce Neal, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Contemporary model for cardiovascular risk prediction in people with type 2 diabetesAndre Pascal Kengne, Anushka Patel, Michel Marre, et al.
Pageof 49

Showing results (271-280 of 484) with videos related to

Sort By:
Pageof 49
Hypertension (Dallas, Tex. : 1979)|August 20, 2003
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibitionStephen B Harrap, Christophe Tzourio, François Cambien, et al.
Clinical Trials (London, England)|February 20, 2008
Do we need to adjudicate major clinical events?Christopher B Granger, Victor Vogel, Steve R Cummings, et al.
Food Research International (Ottawa, Ont.)|May 31, 2021
The adaptation, validation, and application of a methodology for estimating the added sugar content of packaged food products when total and added sugar labels are not mandatoryTailane Scapin, Jimmy Chun Yu Louie, Simone Pettigrew, et al.
BMC Public Health|May 13, 2016
Effects of a community-based salt reduction program in a regional Australian populationMary-Anne Land, Jason H Y Wu, Adriana Selwyn, et al.
JAMA Cardiology|February 5, 2025
Salt Substitution and Recurrent Stroke and Death: A Randomized Clinical TrialXiong Ding, Xinyi Zhang, Liping Huang, et al.
Diabetes Care|June 20, 2022
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)Ele Ferrannini, Simona Baldi, Tiziana Scozzaro, et al.
Circulation|November 15, 2017
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Kenneth W Mahaffey, Bruce Neal, Vlado Perkovic, et al.
The International Journal of Behavioral Nutrition and Physical Activity|December 12, 2022
Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panelDaisy H Coyle, Liping Huang, Maria Shahid, et al.
The Lancet. Planetary Health|December 14, 2024
The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trialBenjamin Talbot, Robert A Fletcher, Bruce Neal, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Contemporary model for cardiovascular risk prediction in people with type 2 diabetesAndre Pascal Kengne, Anushka Patel, Michel Marre, et al.
Pageof 49